Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Lea Nymand"'
Autor:
Yuki M.F. Andersen, MD, PhD, Johan Sieborg, MSc, Lea Nymand, MSc, Tiago Torres, MD, PhD, Andrea Chiricozzi, MD, Simon Francis Thomsen, MD, PhD, DMSc, Jacob P. Thyssen, MD, PhD, DMSc, Alexander Egeberg, MD, PhD, DMSc
Publikováno v:
JAAD International, Vol 17, Iss , Pp 61-66 (2024)
Background: Oral Janus kinase inhibitors (JAKis) have black-box warnings of infections, cancer risk, and cardiovascular and venous thromboembolic events. They may be used off-label for chronic hand eczema (CHE). Objectives: Assess the prevalence of r
Externí odkaz:
https://doaj.org/article/3ba95f7d0da343db9b828f7dff3c40bd
Autor:
Alexander Egeberg, MD, PhD, DMSc, Christoph Schlapbach, MD, PhD, Jeanette Halskou Haugaard, MD, PhD, Lea Nymand, MSc, David Thein, MD, Simon Francis Thomsen, MD, PhD, DMSc, Jacob P. Thyssen, MD, PhD, DMSc
Publikováno v:
JAAD International, Vol 14, Iss , Pp 77-83 (2024)
Background: Topical corticosteroids (TCS) are used to treat most patients with chronic hand eczema (CHE), but knowledge about TCS-related adverse events in CHE is limited. Objectives: To investigate patient-reported adverse events to TCS in CHE patie
Externí odkaz:
https://doaj.org/article/88554a65a6804a75a040e1f6c8186088
Autor:
Alexander Egeberg, Yuki M F Andersen, Amy M DeLozier, Lea Nymand, Russel Burge, Emily Edson-Heredia
Publikováno v:
BMJ Open, Vol 12, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/6ee1a37846c0495696817a5059056c16
Autor:
Lea Nymand, Mia-Louise Nielsen, Alexander Egeberg, Simon Francis Thomsen, Jacob Pontoppidan Thyssen
Publikováno v:
Nielsen, M-L, Nymand, L K, Thomsen, S F, Thyssen, J P & Egeberg, A 2022, ' Delay in diagnosis and treatment of patients with psoriasis : a population-based cross-sectional study ', British Journal of Dermatology, vol. 187, no. 4, pp. 590-591 . https://doi.org/10.1111/bjd.21594
Autor:
Yuki M F Andersen, Lea Nymand, Amy M DeLozier, Russel Burge, Emily Edson-Heredia, Alexander Egeberg
Publikováno v:
Andersen, Y M F, Nymand, L, DeLozier, A M, Burge, R, Edson-Heredia, E & Egeberg, A 2022, ' Patient characteristics and disease burden of alopecia areata in the Danish Skin Cohort ', BMJ Open, vol. 12, no. 2, e053137 . https://doi.org/10.1136/bmjopen-2021-053137
PurposeAlopecia areata (AA) is a common disorder of patchy hair loss which carries a substantial psychological burden for patients. The current understanding of AA prevalence, disease course and burden is limited, and further research is needed to im
Autor:
Alexander Egeberg, Nana Aviaaja Lippert Rosenø, David Aagaard, Erik Hillo Lørup, Mia-Louise Nielsen, Lea Nymand, Lars Erik Kristensen, Jacob P. Thyssen, Simon Francis Thomsen, Rene Lindholm Cordtz, Nikolai Loft, Lone Skov, Lars Erik Bryld, Mads Kirchheiner Rasmussen, Pil Højgaard, Salome Kristensen, Lene Dreyer
Publikováno v:
Egeberg, A, Rosenø, N A L, Aagaard, D, Lørup, E H, Nielsen, M-L, Nymand, L, Kristensen, L E, Thyssen, J P, Thomsen, S F, Cordtz, R L, Loft, N, Skov, L, Bryld, L E, Rasmussen, M K, Højgaard, P, Kristensen, S & Dreyer, L 2022, ' Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis-A nationwide cohort study from the DANBIO and DERMBIO registries ', Seminars in Arthritis and Rheumatism, vol. 53, 151979 . https://doi.org/10.1016/j.semarthrit.2022.151979
Egeberg, A, Rosenø, N A L, Aagaard, D, Lørup, E H, Nielsen, M-L, Nymand, L, Kristensen, L E, Thyssen, J P, Thomsen, S F, Cordtz, R L, Loft, N, Skov, L, Bryld, L E, Rasmussen, M K, Højgaard, P, Kristensen, S & Dreyer, L 2022, ' Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis-A nationwide cohort study from the DANBIO and DERMBIO registries ', Seminars in Arthritis and Rheumatism, vol. 53, pp. 151979 . https://doi.org/10.1016/j.semarthrit.2022.151979
Egeberg, A, Rosenø, N A L, Aagaard, D, Lørup, E H, Nielsen, M L, Nymand, L, Kristensen, L E, Thyssen, J P, Thomsen, S F, Cordtz, R L, Loft, N, Skov, L, Bryld, L E, Rasmussen, M K, Højgaard, P, Kristensen, S & Dreyer, L 2022, ' Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis-A nationwide cohort study from the DANBIO and DERMBIO registries ', Seminars in Arthritis and Rheumatism, vol. 53, 151979 . https://doi.org/10.1016/j.semarthrit.2022.151979
Egeberg, A, Rosenø, N A L, Aagaard, D, Lørup, E H, Nielsen, M-L, Nymand, L, Kristensen, L E, Thyssen, J P, Thomsen, S F, Cordtz, R L, Loft, N, Skov, L, Bryld, L E, Rasmussen, M K, Højgaard, P, Kristensen, S & Dreyer, L 2022, ' Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis-A nationwide cohort study from the DANBIO and DERMBIO registries ', Seminars in Arthritis and Rheumatism, vol. 53, pp. 151979 . https://doi.org/10.1016/j.semarthrit.2022.151979
Egeberg, A, Rosenø, N A L, Aagaard, D, Lørup, E H, Nielsen, M L, Nymand, L, Kristensen, L E, Thyssen, J P, Thomsen, S F, Cordtz, R L, Loft, N, Skov, L, Bryld, L E, Rasmussen, M K, Højgaard, P, Kristensen, S & Dreyer, L 2022, ' Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis-A nationwide cohort study from the DANBIO and DERMBIO registries ', Seminars in Arthritis and Rheumatism, vol. 53, 151979 . https://doi.org/10.1016/j.semarthrit.2022.151979
OBJECTIVE: Drug survival is an important proxy measure for effectiveness of treatments for inflammatory diseases such as rheumatoid arthritis (RA), axial spondyloarthritis (AxSpA), psoriatic arthritis (PsA), and psoriasis. The objective of this study
Publikováno v:
Dermatitis (Mary Ann Liebert, Inc.); May/Jun2024, Vol. 35 Issue 3, pe314-e329, 16p
Publikováno v:
Obesity, Fitness & Wellness Week; 12/10/2024, p1290-1290, 1p
Publikováno v:
Health & Medicine Week; 3/15/2024, p5687-5687, 1p
Autor:
A. Egeberg, N. Lippert Rosenoe, D. Aagaard, E. Lørup, L. Nymand, L. E. Kristensen, J. Thyssen, S. F. Thomsen, R. L. Cordtz, N. Loft, L. Skov, L. E. Bryld, M. Rasmussen, P. Højgaard, S. Kristensen, L. Dreyer
Publikováno v:
Annals of the Rheumatic Diseases. 81:256-257
BackgroundDrug survival is an important proxy measure for effectiveness of treatments for inflammatory diseases such as rheumatoid arthritis (RA), axial spondyloarthritis (AxSpA), psoriatic arthritis (PsA), and psoriasis [1-4].ObjectivesThe objective